Clinical treatment options for early-stage and advanced conjunctival melanoma
Yue Zeng(Shandong University), Fang Wu(Central South University), Xingxiang Pu(Central South University), Lishu Zhao(Central South University), Chunhong Hu(Central South University), Yue Pan(Shandong University), Long Shu(Central South University)
Cited by 28
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application
|Clinical Epigenetics|2021|253
Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer
|Nature Medicine|2024|116
The Resistance Mechanisms and Treatment Strategies for ALK-Rearranged Non-Small Cell Lung Cancer
|Frontiers in Oncology|2021|111
Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients
|Diabetes Research and Clinical Practice|2014|92